Insight Molecular Diagnostics Inc.
IMDX
$3.41
$0.041.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -115.06% | 26.93% | -109.55% | -107.94% | 45.64% |
| Total Depreciation and Amortization | 71.47% | 46.57% | 73.23% | -20.19% | -28.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 668.40% | -65.37% | 144.64% | 248.65% | -122.43% |
| Change in Net Operating Assets | 59.46% | -202.45% | -127.25% | -101.77% | 26.72% |
| Cash from Operations | -5.04% | -52.95% | -21.02% | -47.28% | 12.50% |
| Capital Expenditure | -82.72% | -1,179.17% | 18.94% | -411.76% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -82.72% | -1,179.17% | -303.88% | -140.65% | -255.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -245.45% | -- | -173.33% | -186.67% | -13.79% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | 14.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -382.02% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -26.00% |
| Cash from Financing | -101.16% | -- | 36,223.33% | -750.00% | -19.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -283.31% | 681.03% | 221.19% | -64.38% | -33.91% |